“There’s an amazing amount of innovation and digital experimentation happening right now in health care; something is going to catch hold. I don’t doubt that in five years your health care experience will be dramatically improved due to business model innovation made possible through the digitization of medical record data.”
– Niko Skievaski, Redox President & Co-Founder
Scalable Infrastructure to Support Empathetic Healthcare
Redox is obsessed with improving patient care and provider performance by simplifying how healthcare shares data. Founded in 2014 by Niko Skievaski, James Lloyd, and Luke Bonney, Redox exists to improve healthcare by uniting patients and providers through easily accessible technology. The goal is to make healthcare data useful and every patient experience a little bit better. When done right, technology removes distractions so providers can focus on what’s important: their patients.
Redox accelerates the development and distribution of digital health solutions with a full-service healthcare integration platform to securely and efficiently exchange data. Healthcare organizations and technology vendors connect once and authorize the data they send and receive across the most extensive interoperable network in healthcare.
“With so many pre-built connections to major hospital systems, more and more companies want to sign up with us. Basically anyone looking to scale and grow quickly now has a compelling reason to choose Redox.”
–Niko Skievaski, Redox Co-founder & President.
We participate as a way to grow our connections and relationships with the Prime Health community. Having the chance to learn about what people are doing, where there are challenges, and to educate on what Redox does is the most important part of attending the conference. We’re looking forward to learning more about the challenges in our healthcare system and the innovative solutions being created to address them really drives home Redox‘s mission of making healthcare data useful.
Also, congratulations to Redox on recently closing a $33 million Series C funding round led by global investment firm Battery Ventures with participation from existing investors .406 Ventures, RRE Ventures, and Intermountain Ventures! Read more about their exciting announcement here.
“If you think about the data that is currently locked up in our health systems, that’s first and foremost an infrastructure problem. When we think about the next things to do, we think of things like cleaning that data, scrubbing and organizing it in a way to continue to learn from it and drive value,”
– Redox CEO and Co-Founder, Luke Bonney